CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma

Abstract
Key Points T cells genetically targeted to the tumor-promoting antigen CD44v6 are effective against AML and MM. CD44v6-targeted T cells do not recognize hematopoietic stem cells and keratinocytes but cause reversible monocytopenia.

This publication has 49 references indexed in Scilit: